[1]
F. Javaid, “In Silico Discovery of Cefoperazone as a Novel MMP-2 Inhibitor for Ovarian Cancer Therapy”, Sci Inquiry Rev, vol. 9, no. 2, pp. 64-84, Jun. 2025.